Using shRNA-mediated FTO knockdown, we further confirmed that genetic inhibition of FTO promotes DNA damage and reduces ccRCC growth and survival through the regulation of pyrimidine biosynthesis and ROS. This evidence concerns the gene FTO and nonpapillary renal cell carcinoma.